Others have targeted AKT in combination with MEK inhibition, which showed induced activation of AMP-activated protein kinase, resulted in the synergistic induction of autophagic cell death in UM cells, and inhibited UM tumor growth in xenograft mouse models [81]. The gene discussed is MAP2K7; the disease is neoplasm.